Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Catheter EquipmentCardiovascular Device

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1744962

Cover Image

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1744962

Aortic Valves

PUBLISHED:
PAGES: 268 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License)
USD 5850
PDF (Global License to Company and its Fully-owned Subsidiaries)
USD 17550

Add to Cart

Description

Table of Contents

Global Aortic Valves Market to Reach US$9.8 Billion by 2030

The global market for Aortic Valves estimated at US$6.1 Billion in the year 2024, is expected to reach US$9.8 Billion by 2030, growing at a CAGR of 8.2% over the analysis period 2024-2030. Mechanical Valves, one of the segments analyzed in the report, is expected to record a 7.1% CAGR and reach US$5.8 Billion by the end of the analysis period. Growth in the Biological Valves segment is estimated at 10.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.7 Billion While China is Forecast to Grow at 12.6% CAGR

The Aortic Valves market in the U.S. is estimated at US$1.7 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$2.1 Billion by the year 2030 trailing a CAGR of 12.6% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.2% and 7.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.5% CAGR.

Global Aortic Valves Market - Key Trends & Drivers Summarized

Why Are Aortic Valves Central to the Management of Structural Heart Disease in Aging Populations?

Aortic valves play a vital role in regulating unidirectional blood flow from the left ventricle to the aorta, and their dysfunction-typically stenosis or regurgitation-leads to significant cardiac morbidity and mortality. Aortic valve replacement (AVR), through either surgical or transcatheter approaches, has become a cornerstone intervention in structural heart disease, particularly among elderly patients with degenerative valve conditions. With the global burden of aortic stenosis rising in parallel with aging demographics, aortic valves are increasingly viewed as life-saving implants for restoring cardiac function, relieving symptoms, and improving survival rates.

Historically, surgical aortic valve replacement (SAVR) was the standard of care, requiring open-heart surgery with cardiopulmonary bypass. However, the advent of transcatheter aortic valve replacement (TAVR)-a minimally invasive approach-has transformed treatment paradigms, expanding access to patients previously deemed inoperable or high-risk for surgery. TAVR’s use has since expanded to intermediate and low-risk groups, reinforcing its role as a first-line therapy across broader patient cohorts. This shift is being fueled by favorable clinical trial data demonstrating comparable or superior outcomes relative to SAVR in appropriate candidates.

Beyond stenosis, aortic valve interventions are gaining ground in the management of bicuspid valve disease, valve-in-valve procedures for degenerated bioprostheses, and combined valvular pathologies requiring multi-valve interventions. The growing prevalence of heart failure, calcific valve degeneration, and increased screening in asymptomatic patients is further driving procedural volume. As life expectancy increases and cardiovascular disease remains a global health priority, aortic valve replacement continues to serve as a critical intervention in contemporary cardiology.

How Are Device Innovations and Procedural Technologies Enhancing Valve Performance and Patient Outcomes?

Innovations in valve design are improving hemodynamic performance, durability, and implantability of both surgical and transcatheter aortic valves. Bioprosthetic valves-constructed from bovine or porcine pericardial tissue-are now treated with anti-calcification agents and mounted on flexible frames to reduce immune response and extend lifespan. New-generation TAVR systems offer repositionable and retrievable features, lower-profile delivery catheters, and enhanced radial strength for secure anchoring, even in anatomically challenging cases such as severely calcified or bicuspid aortic roots.

Advancements in pre-procedural imaging, especially multidetector CT and 3D echocardiography, have enabled more precise patient selection, annular sizing, and procedural planning. Integration of imaging with digital navigation platforms and real-time fluoroscopic guidance has minimized paravalvular leak, vascular injury, and conduction disturbances. In addition, intraprocedural innovations such as cerebral embolic protection devices and conscious sedation protocols are improving safety profiles and enabling shorter recovery times.

Durability remains a central focus of innovation, particularly as younger and lower-risk patients undergo TAVR. Ongoing trials are assessing leaflet longevity, structural valve deterioration, and thrombogenicity to support long-term adoption. Polymer-based leaflet designs, tissue-engineered scaffolds, and anti-thrombotic coatings are being explored to extend valve life beyond current bioprosthetic limits. Meanwhile, efforts to standardize valve-in-valve procedures, optimize hemodynamics in small annuli, and reduce pacemaker dependency are pushing the next frontier in device evolution.

Which Patient Segments and Regional Markets Are Fueling Demand for Aortic Valve Interventions?

The primary drivers of aortic valve replacement remain elderly patients with symptomatic severe aortic stenosis, particularly in North America and Western Europe where diagnostic access, procedural infrastructure, and reimbursement models are well-established. However, the increasing use of echocardiographic screening and growing awareness of heart valve disease are expanding referrals even among asymptomatic patients and moderate-risk groups. TAVR is increasingly preferred for frail patients, those with prior cardiac surgery, and those with anatomical complexities that increase open-surgery risk.

Younger patients and those with bicuspid valves are emerging as an important focus, particularly in markets where average age at diagnosis is lower or where SAVR remains the default due to reimbursement constraints. The valve-in-valve segment is also growing rapidly as the first wave of bioprosthetic implants begins to degenerate. This is creating a new layer of demand for redo TAVR procedures, supported by growing evidence of safety and efficacy in reinterventions.

Geographically, North America holds the largest market share, followed by Europe, driven by high procedural volumes, advanced healthcare infrastructure, and established training ecosystems. Asia-Pacific represents the fastest-growing region due to expanding healthcare access, increasing awareness of valvular heart disease, and rapid growth in private cardiovascular centers across China, India, Japan, and Southeast Asia. Meanwhile, adoption in Latin America, the Middle East, and parts of Africa is supported by public-private partnerships, medical tourism, and growing investment in tertiary cardiovascular care infrastructure.

How Are Regulatory Developments, Value-Based Care Models, and Clinical Evidence Influencing Market Expansion?

The regulatory landscape for aortic valve devices is evolving rapidly, with authorities accelerating approval pathways for TAVR systems through priority review, breakthrough designation, and reliance on global clinical data. Agencies such as the FDA and EMA have expanded device indications from high-risk to intermediate- and low-risk patients, driving broader procedural eligibility and insurance coverage. Post-market surveillance and registries-such as TVT in the U.S. and NOTION in Europe-are providing long-term outcomes data that support ongoing reimbursement and guideline inclusion.

As healthcare systems adopt value-based models, cost-effectiveness and quality-of-life improvements are becoming pivotal to technology adoption. Numerous health economic studies have shown that TAVR, despite higher upfront costs, offers long-term value through reduced rehospitalization, improved functional outcomes, and lower mortality in eligible populations. Hospitals are increasingly selecting valve platforms based on procedure success rates, reintervention risk, and compatibility with evolving treatment protocols across multi-disciplinary heart teams.

Clinical guidelines from societies such as the ESC, AHA/ACC, and JCS are incorporating TAVR into mainstream recommendations for a broader patient population. Simultaneously, global training initiatives and cross-border knowledge exchange are supporting operator proficiency and standardization of care. As procedural outcomes improve and stakeholders demand data-backed decision-making, clinical evidence will remain a cornerstone of market growth and strategic differentiation among device manufacturers.

What Are the Factors Driving Growth in the Aortic Valves Market?

The aortic valves market is experiencing robust growth, fueled by the global rise in valvular heart disease, expanded eligibility for minimally invasive interventions, and the continuous shift toward patient-centered, evidence-based cardiovascular care. Key drivers include aging populations, increased screening, evolving treatment guidelines, and growing comfort with TAVR in younger and lower-risk cohorts. The transition from surgical to catheter-based interventions is particularly transformative in terms of procedural volume and accessibility.

Technological differentiation, long-term durability, and clinical versatility are becoming critical to market competitiveness as stakeholders demand personalized, data-driven care pathways. Meanwhile, market expansion is supported by rising investment in hybrid ORs, specialized heart valve centers, and cross-functional cardiovascular teams trained in advanced valve therapies. As global health systems prioritize efficient, minimally invasive, and high-value care, aortic valve technologies are emerging as essential tools in structural heart disease management.

Looking forward, the evolution of the aortic valves market will depend on how effectively the next generation of devices balances performance, durability, and affordability across diverse healthcare settings. As precision cardiology converges with minimally invasive technologies, could aortic valves represent the central node of a global shift toward preventative and restorative heart care?

SCOPE OF STUDY:

The report analyzes the Aortic Valves market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Valve Type (Mechanical Valves, Biological Valves); End-Use (Hospitals, Ambulatory Surgery Centers, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 34 Featured) -

  • Abbott Laboratories
  • Anteris Technologies Ltd.
  • Artivion Inc.
  • AutoTissue GmbH
  • Boston Scientific Corporation
  • CarboMedics Inc.
  • Cardiac Dimensions Inc.
  • Cardiosolutions Inc.
  • Corcym Inc.
  • CryoLife Inc.
  • Edwards Lifesciences
  • Endovalve Inc.
  • Foldax Inc.
  • JenaValve Technology Inc.
  • Leman Cardiovascular
  • LivaNova PLC
  • Medtentia AB
  • Medtronic Plc
  • MiCardia Corporation
  • MitralSolutions Inc.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA <> CHINA <> MEXICO <> CANADA <> EU <> JAPAN <> INDIA <> 176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

COMPLIMENTARY PREVIEW

Contact your sales agent to request an online 300+ page complimentary preview of this research project. Our preview will present full stack sources, and validated domain expert data transcripts. Deep dive into our interactive data-driven online platform.

Show more
Product Code: MCP34610

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Aortic Valves - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Aortic Stenosis and Valve Disease Throws the Spotlight on Aortic Valve Replacement
    • Growth in Transcatheter Aortic Valve Replacement (TAVR) Procedures Spurs Minimally Invasive Treatment Demand
    • OEM Innovations in Tissue-Engineered and Self-Expanding Valves Strengthen Market Penetration
    • Increasing Use of Bioprosthetic Valves in Aging Populations Supports Shift Away From Mechanical Alternatives
    • Expansion of Valve-in-Valve Procedures Bodes Well for TAVR in Failed Surgical Valve Replacements
    • Advancements in Imaging-Guided Implantation Improve Procedural Accuracy and Clinical Outcomes
    • Growth in Aortic Valve Clinics and Multidisciplinary Heart Teams Enhances Patient Selection and Preoperative Planning
    • Rise in Early Intervention Guidelines and Lower-Risk Patient Approvals Accelerates Market Growth
    • Integration of AI and Predictive Modeling Supports Personalized Valve Selection and Post-Procedure Management
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Aortic Valves Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Aortic Valves by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Aortic Valves by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Aortic Valves by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Mechanical Valves by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Mechanical Valves by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Mechanical Valves by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Biological Valves by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Biological Valves by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Biological Valves by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Ambulatory Surgery Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Aortic Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 20: USA Recent Past, Current & Future Analysis for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 21: USA Historic Review for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: USA 15-Year Perspective for Aortic Valves by Valve Type - Percentage Breakdown of Value Sales for Mechanical Valves and Biological Valves for the Years 2015, 2025 & 2030
    • TABLE 23: USA Recent Past, Current & Future Analysis for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: USA 15-Year Perspective for Aortic Valves by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 27: Canada Historic Review for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: Canada 15-Year Perspective for Aortic Valves by Valve Type - Percentage Breakdown of Value Sales for Mechanical Valves and Biological Valves for the Years 2015, 2025 & 2030
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: Canada 15-Year Perspective for Aortic Valves by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • JAPAN
    • Aortic Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Japan Historic Review for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: Japan 15-Year Perspective for Aortic Valves by Valve Type - Percentage Breakdown of Value Sales for Mechanical Valves and Biological Valves for the Years 2015, 2025 & 2030
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: Japan 15-Year Perspective for Aortic Valves by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • CHINA
    • Aortic Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 38: China Recent Past, Current & Future Analysis for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: China Historic Review for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: China 15-Year Perspective for Aortic Valves by Valve Type - Percentage Breakdown of Value Sales for Mechanical Valves and Biological Valves for the Years 2015, 2025 & 2030
    • TABLE 41: China Recent Past, Current & Future Analysis for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: China 15-Year Perspective for Aortic Valves by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • EUROPE
    • Aortic Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Aortic Valves by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 45: Europe Historic Review for Aortic Valves by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: Europe 15-Year Perspective for Aortic Valves by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: Europe 15-Year Perspective for Aortic Valves by Valve Type - Percentage Breakdown of Value Sales for Mechanical Valves and Biological Valves for the Years 2015, 2025 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: Europe 15-Year Perspective for Aortic Valves by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • FRANCE
    • Aortic Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 53: France Recent Past, Current & Future Analysis for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: France Historic Review for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: France 15-Year Perspective for Aortic Valves by Valve Type - Percentage Breakdown of Value Sales for Mechanical Valves and Biological Valves for the Years 2015, 2025 & 2030
    • TABLE 56: France Recent Past, Current & Future Analysis for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: France 15-Year Perspective for Aortic Valves by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • GERMANY
    • Aortic Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 59: Germany Recent Past, Current & Future Analysis for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Germany Historic Review for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: Germany 15-Year Perspective for Aortic Valves by Valve Type - Percentage Breakdown of Value Sales for Mechanical Valves and Biological Valves for the Years 2015, 2025 & 2030
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: Germany 15-Year Perspective for Aortic Valves by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 65: Italy Recent Past, Current & Future Analysis for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Italy Historic Review for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: Italy 15-Year Perspective for Aortic Valves by Valve Type - Percentage Breakdown of Value Sales for Mechanical Valves and Biological Valves for the Years 2015, 2025 & 2030
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: Italy 15-Year Perspective for Aortic Valves by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Aortic Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 71: UK Recent Past, Current & Future Analysis for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: UK Historic Review for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: UK 15-Year Perspective for Aortic Valves by Valve Type - Percentage Breakdown of Value Sales for Mechanical Valves and Biological Valves for the Years 2015, 2025 & 2030
    • TABLE 74: UK Recent Past, Current & Future Analysis for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: UK 15-Year Perspective for Aortic Valves by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 77: Spain Recent Past, Current & Future Analysis for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Spain Historic Review for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: Spain 15-Year Perspective for Aortic Valves by Valve Type - Percentage Breakdown of Value Sales for Mechanical Valves and Biological Valves for the Years 2015, 2025 & 2030
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: Spain 15-Year Perspective for Aortic Valves by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 83: Russia Recent Past, Current & Future Analysis for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Russia Historic Review for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: Russia 15-Year Perspective for Aortic Valves by Valve Type - Percentage Breakdown of Value Sales for Mechanical Valves and Biological Valves for the Years 2015, 2025 & 2030
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: Russia 15-Year Perspective for Aortic Valves by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 89: Rest of Europe Recent Past, Current & Future Analysis for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Rest of Europe Historic Review for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: Rest of Europe 15-Year Perspective for Aortic Valves by Valve Type - Percentage Breakdown of Value Sales for Mechanical Valves and Biological Valves for the Years 2015, 2025 & 2030
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Rest of Europe 15-Year Perspective for Aortic Valves by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Aortic Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 95: Asia-Pacific Recent Past, Current & Future Analysis for Aortic Valves by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 96: Asia-Pacific Historic Review for Aortic Valves by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Asia-Pacific 15-Year Perspective for Aortic Valves by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Asia-Pacific 15-Year Perspective for Aortic Valves by Valve Type - Percentage Breakdown of Value Sales for Mechanical Valves and Biological Valves for the Years 2015, 2025 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 15-Year Perspective for Aortic Valves by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Aortic Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 104: Australia Recent Past, Current & Future Analysis for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Australia Historic Review for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Australia 15-Year Perspective for Aortic Valves by Valve Type - Percentage Breakdown of Value Sales for Mechanical Valves and Biological Valves for the Years 2015, 2025 & 2030
    • TABLE 107: Australia Recent Past, Current & Future Analysis for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Australia 15-Year Perspective for Aortic Valves by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • INDIA
    • Aortic Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 110: India Recent Past, Current & Future Analysis for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: India Historic Review for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: India 15-Year Perspective for Aortic Valves by Valve Type - Percentage Breakdown of Value Sales for Mechanical Valves and Biological Valves for the Years 2015, 2025 & 2030
    • TABLE 113: India Recent Past, Current & Future Analysis for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: India Historic Review for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: India 15-Year Perspective for Aortic Valves by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 116: South Korea Recent Past, Current & Future Analysis for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: South Korea Historic Review for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: South Korea 15-Year Perspective for Aortic Valves by Valve Type - Percentage Breakdown of Value Sales for Mechanical Valves and Biological Valves for the Years 2015, 2025 & 2030
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: South Korea 15-Year Perspective for Aortic Valves by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 122: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Rest of Asia-Pacific Historic Review for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: Rest of Asia-Pacific 15-Year Perspective for Aortic Valves by Valve Type - Percentage Breakdown of Value Sales for Mechanical Valves and Biological Valves for the Years 2015, 2025 & 2030
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 15-Year Perspective for Aortic Valves by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Aortic Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 128: Latin America Recent Past, Current & Future Analysis for Aortic Valves by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 129: Latin America Historic Review for Aortic Valves by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: Latin America 15-Year Perspective for Aortic Valves by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: Latin America 15-Year Perspective for Aortic Valves by Valve Type - Percentage Breakdown of Value Sales for Mechanical Valves and Biological Valves for the Years 2015, 2025 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: Latin America 15-Year Perspective for Aortic Valves by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 137: Argentina Recent Past, Current & Future Analysis for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Argentina Historic Review for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: Argentina 15-Year Perspective for Aortic Valves by Valve Type - Percentage Breakdown of Value Sales for Mechanical Valves and Biological Valves for the Years 2015, 2025 & 2030
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: Argentina 15-Year Perspective for Aortic Valves by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 143: Brazil Recent Past, Current & Future Analysis for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Brazil Historic Review for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: Brazil 15-Year Perspective for Aortic Valves by Valve Type - Percentage Breakdown of Value Sales for Mechanical Valves and Biological Valves for the Years 2015, 2025 & 2030
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Brazil 15-Year Perspective for Aortic Valves by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 149: Mexico Recent Past, Current & Future Analysis for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Mexico Historic Review for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 151: Mexico 15-Year Perspective for Aortic Valves by Valve Type - Percentage Breakdown of Value Sales for Mechanical Valves and Biological Valves for the Years 2015, 2025 & 2030
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 154: Mexico 15-Year Perspective for Aortic Valves by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 155: Rest of Latin America Recent Past, Current & Future Analysis for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Rest of Latin America Historic Review for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 157: Rest of Latin America 15-Year Perspective for Aortic Valves by Valve Type - Percentage Breakdown of Value Sales for Mechanical Valves and Biological Valves for the Years 2015, 2025 & 2030
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 160: Rest of Latin America 15-Year Perspective for Aortic Valves by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Aortic Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 161: Middle East Recent Past, Current & Future Analysis for Aortic Valves by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 162: Middle East Historic Review for Aortic Valves by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 163: Middle East 15-Year Perspective for Aortic Valves by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 166: Middle East 15-Year Perspective for Aortic Valves by Valve Type - Percentage Breakdown of Value Sales for Mechanical Valves and Biological Valves for the Years 2015, 2025 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 169: Middle East 15-Year Perspective for Aortic Valves by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 170: Iran Recent Past, Current & Future Analysis for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Iran Historic Review for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 172: Iran 15-Year Perspective for Aortic Valves by Valve Type - Percentage Breakdown of Value Sales for Mechanical Valves and Biological Valves for the Years 2015, 2025 & 2030
    • TABLE 173: Iran Recent Past, Current & Future Analysis for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 175: Iran 15-Year Perspective for Aortic Valves by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 176: Israel Recent Past, Current & Future Analysis for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Israel Historic Review for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 178: Israel 15-Year Perspective for Aortic Valves by Valve Type - Percentage Breakdown of Value Sales for Mechanical Valves and Biological Valves for the Years 2015, 2025 & 2030
    • TABLE 179: Israel Recent Past, Current & Future Analysis for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 181: Israel 15-Year Perspective for Aortic Valves by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 182: Saudi Arabia Recent Past, Current & Future Analysis for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Saudi Arabia Historic Review for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 184: Saudi Arabia 15-Year Perspective for Aortic Valves by Valve Type - Percentage Breakdown of Value Sales for Mechanical Valves and Biological Valves for the Years 2015, 2025 & 2030
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 187: Saudi Arabia 15-Year Perspective for Aortic Valves by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 188: UAE Recent Past, Current & Future Analysis for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: UAE Historic Review for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 190: UAE 15-Year Perspective for Aortic Valves by Valve Type - Percentage Breakdown of Value Sales for Mechanical Valves and Biological Valves for the Years 2015, 2025 & 2030
    • TABLE 191: UAE Recent Past, Current & Future Analysis for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 193: UAE 15-Year Perspective for Aortic Valves by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 194: Rest of Middle East Recent Past, Current & Future Analysis for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Rest of Middle East Historic Review for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 196: Rest of Middle East 15-Year Perspective for Aortic Valves by Valve Type - Percentage Breakdown of Value Sales for Mechanical Valves and Biological Valves for the Years 2015, 2025 & 2030
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 199: Rest of Middle East 15-Year Perspective for Aortic Valves by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • AFRICA
    • Aortic Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 200: Africa Recent Past, Current & Future Analysis for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Africa Historic Review for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 202: Africa 15-Year Perspective for Aortic Valves by Valve Type - Percentage Breakdown of Value Sales for Mechanical Valves and Biological Valves for the Years 2015, 2025 & 2030
    • TABLE 203: Africa Recent Past, Current & Future Analysis for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 205: Africa 15-Year Perspective for Aortic Valves by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030

IV. COMPETITION

Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!